Literature DB >> 12775683

Effect of D240G substitution in a novel ESBL CTX-M-27.

R Bonnet1, C Recule, R Baraduc, C Chanal, D Sirot, C De Champs, J Sirot.   

Abstract

Escherichia coli clinical strain Gre-1 collected in 2000 from a French hospital harboured a novel CTX-M-encoding gene, designated blaCTX-M-27. CTX-M-27 differed from CTX-M-14 only by the substitution D240G and was the third CTX-M enzyme harbouring this mutation after CTX-M-15 and CTX-M-16. The Gly-240-harbouring enzyme CTX-M-27 conferred to E. coli higher MICs of ceftazidime (MIC, 8 versus 1 mg/L) than did the Asp-240-harbouring CTX-M-14 enzyme. Comparison of CTX-M-14 and CTX-M-27 showed that residue Gly-240 decreased Km for ceftazidime (205 versus 940 microM), but decreased hydrolytic activity against good substrates, such as cefotaxime (kcat, 113 versus 415 s-1), probably owing to the alteration of beta3 strand positioning during the catalytic process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775683     DOI: 10.1093/jac/dkg256

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  55 in total

1.  Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm.

Authors:  Junying Ma; Jian-Hua Liu; Luchao Lv; Zhiyong Zong; Yan Sun; Hongqing Zheng; ZhangLiu Chen; Zhen-Ling Zeng
Journal:  Appl Environ Microbiol       Date:  2012-03-09       Impact factor: 4.792

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.

Authors:  Monica Cartelle; Maria del Mar Tomas; Francisca Molina; Rita Moure; Rosa Villanueva; German Bou
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Molecular and kinetic comparison of the novel extended-spectrum beta-lactamases CTX-M-25 and CTX-M-26.

Authors:  Craig J Munday; David A Boyd; Nigel Brenwald; Mark Miller; Jennifer M Andrews; Richard Wise; Michael R Mulvey; Peter M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia.

Authors:  Olfa Bouallègue-Godet; Youssef Ben Salem; Laëtitia Fabre; Marie Demartin; Patrick A D Grimont; Ridha Mzoughi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada.

Authors:  Baha Abdalhamid; Johann D D Pitout; Ellen S Moland; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.

Authors:  J Delmas; F Robin; F Carvalho; C Mongaret; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.

Authors:  Yukiko Nagano; Noriyuki Nagano; Jun-ichi Wachino; Keiko Ishikawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

9.  Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae.

Authors:  Jun Cheng; Wei Gao; Jun Yin; Zhen Sun; Ying Ye; Yu-Feng Gao; Xu Li; Jia-Bin Li
Journal:  Mol Biol Rep       Date:  2009-03-18       Impact factor: 2.316

10.  Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Authors:  David A Boyd; Shaun Tyler; Sara Christianson; Allison McGeer; Matthew P Muller; Barbara M Willey; Elizabeth Bryce; Michael Gardam; Patrice Nordmann; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.